
Senate Finance Committee leaders, Mike Crapo and Ron Wyden, rallied with pharmacists and advocates at the Capitol on a spring morning to push for the passage of a bipartisan Pharmacy Benefit Manager (PBM) reform bill by March 22. The bill, which passed the Finance Committee last fall with a 26-0 vote, aims to lower drug costs and hold pharma middlemen accountable. In addition to PBM reform, efforts led by Rep. Spanberger and @RepDonBacon seek to reduce dependency on foreign sources like the Chinese Communist Party for pharmaceutical ingredients. Senators are working to include the PBM reform in the upcoming government funding bill, with substantial bipartisan and bicameral support from figures like @MikeJohnson, @RepJeffries, @LeaderMcConnell, and @SenSchumer. However, securing the backing of key congressional leaders and committees, including Neal and Scott, remains a challenge.
Enacting effective legislation to fix drug shortages requires bipartisan, bicameral collaboration. I will continue to work on solutions to end drug shortages and provide Idahoans and Americans nationwide with better, more cost-effective health care. https://t.co/xYV7BsHcDN
Scoop: Committees in both chambers/parties are close to a deal on PBM/transparency/community health center $ package to attach to funding bill --But Neal, Scott, not on board, and neither is leadership yet, who this cld be too much of headahce for https://t.co/t7j8mscgr4
The United States should not have to depend on our adversaries — like the Chinese Communist Party — for key ingredients in drugs Americans rely on. That's why I'm leading an effort with @RepDonBacon to prevent drug shortages & manufacture more pharmaceutical ingredients at home.




